Home › Companies › Quest Diagnostics Incorporated › 2025-2026
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and Quest Diagnostics Incorporated’s Form 8-K, filed May 21, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of May 20, 2026: 14 items on Quest Diagnostics Incorporated’s Form 8-K, filed May 21, 2026: 11 elected · 2 approved · 1 not approved.
Significant dissent: 1 shareholder proposal (25.6% support).
Notable dissent: 2 directors (12.8%, 10.9% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore Quest Diagnostics Incorporated in the interactive database Compare manager voting policies
These tallies are Quest Diagnostics Incorporated’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 21, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Robert B. Carter | 93,821,069 | 205,166 | 173,510 | -- | 9,135,906 | 99.8% | Elected | — |
| Elect Director: James E. Davis | 88,799,800 | 5,237,756 | 162,189 | -- | 9,135,906 | 94% | Elected | — |
| Elect Director: Luis A. Diaz, Jr., M.D. | 93,909,369 | 110,114 | 180,262 | -- | 9,135,906 | 99.9% | Elected | — |
| Elect Director: Tracey C. Doi | 93,649,938 | 393,268 | 156,539 | -- | 9,135,906 | 99.6% | Elected | — |
| Elect Director: Vicky B. Gregg | 83,814,387 | 10,232,574 | 152,784 | -- | 9,135,906 | 89% | Elected | — |
| Elect Director: Wright L. Lassiter, III | 93,802,306 | 223,154 | 174,285 | -- | 9,135,906 | 99.8% | Elected | — |
| Elect Director: Timothy L. Main | 88,302,767 | 5,614,920 | 282,058 | -- | 9,135,906 | 94% | Elected | — |
| Elect Director: Denise M. Morrison | 89,808,461 | 4,176,407 | 214,877 | -- | 9,135,906 | 96% | Elected | — |
| Elect Director: Gary M. Pfeiffer | 86,302,153 | 7,716,970 | 180,622 | -- | 9,135,906 | 92% | Elected | — |
| Elect Director: Timothy M. Ring | 81,917,543 | 11,994,424 | 287,778 | -- | 9,135,906 | 87% | Elected | — |
| Elect Director: Timothy C. Wentworth | 93,427,490 | 597,095 | 175,160 | -- | 9,135,906 | 99.4% | Elected | — |
| Advisory resolution to approve the executive officer compensation disclosed in the Company's 2026 Proxy Statement | 86,869,738 | 7,152,448 | 177,559 | -- | 9,135,906 | 92% | Approved | — |
| The ratification of the appointment of PricewaterhouseCoopers as the Company's independent registered public accounting firm for 2026 | 97,340,034 | 5,809,995 | 185,622 | -- | -- | 94% | Approved | — |
| Stockholder proposal regarding an independent board chairman | 23,999,636 | 69,792,819 | 407,290 | -- | 9,135,906 | 26% | Not approved | — |
Source: Quest Diagnostics Incorporated, Form 8-K, filed with the SEC on May 21, 2026 — read the filing on EDGAR.
See voting trends for Health Care companies, 2025-2026: shareholder support by sector and by company size.
928 asset managers disclosed a vote on at least one Quest Diagnostics Incorporated item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 7 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Prior year: 97.7% for (May 15, 2025 meeting) ▼ 2.2 pts
Description as filed by funds: Election of Directors: Denise M. Morrison
Quest Diagnostics Incorporated’s own tally for this item (“Elect Director: Denise M. Morrison”): 89,808,461 for, 4,176,407 against, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “(b) The following nominees for the office of director were elected for terms expiring at the 2027 Annual Meeting of Stockholders, by the following votes:”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 175 asset managers below reported 42,495,294 for, 26,945 against, 21,459 abstained, 93 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,286,610 | 74 | 4 | 0 | For |
| BlackRock | 3,527,385 | 0 | 0 | 0 | For |
| Fidelity | 3,397,386 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,298,943 | 0 | 0 | 0 | For |
| JPMorgan | 2,658,066 | 0 | 0 | 0 | For |
| John Hancock | 2,247,454 | 0 | 0 | 0 | For |
| Invesco | 1,458,667 | 0 | 0 | 0 | For |
| Victory Capital | 1,337,197 | 0 | 0 | 0 | For |
| State Street | 1,254,570 | 0 | 0 | 0 | For |
| Dimensional | 935,911 | 0 | 0 | 0 | For |
| Charles Schwab | 738,419 | 0 | 0 | 0 | For |
| GMO | 568,962 | 0 | 0 | 0 | For |
| American Century | 567,125 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 472,066 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 429,772 | 0 | 0 | 0 | For |
| TIAA | 377,914 | 0 | 0 | 0 | For |
| DAVIS NEW YORK VENTURE FUND INC | 364,350 | 0 | 0 | 0 | For |
| Principal | 330,378 | 0 | 0 | 0 | For |
| First Trust | 315,132 | 0 | 0 | 0 | For |
| DAVIS SERIES INC | 276,843 | 0 | 0 | 0 | For |
| Jackson National | 254,082 | 0 | 0 | 0 | For |
| Goldman Sachs | 207,232 | 0 | 0 | 0 | For |
| FMI FUNDS INC | 190,000 | 0 | 0 | 0 | For |
| Lincoln Financial | 185,672 | 0 | 0 | 0 | For |
| GMO ETF Trust | 176,930 | 0 | 0 | 0 | For |
Showing the 25 largest of 175 asset managers. All 175 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
92% Majority: yes · of votes cast
Prior year: 94.1% for (May 15, 2025 meeting) ▼ 2.3 pts
Description as filed by funds: Election of Directors: Gary M. Pfeiffer
Quest Diagnostics Incorporated’s own tally for this item (“Elect Director: Gary M. Pfeiffer”): 86,302,153 for, 7,716,970 against, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “(b) The following nominees for the office of director were elected for terms expiring at the 2027 Annual Meeting of Stockholders, by the following votes:”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 175 asset managers below reported 42,279,433 for, 242,807 against, 21,457 abstained, 93 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,269,276 | 17,409 | 2 | 0 | For |
| BlackRock | 3,527,009 | 376 | 0 | 0 | For |
| Fidelity | 3,397,386 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,298,943 | 0 | 0 | 0 | For |
| JPMorgan | 2,658,066 | 0 | 0 | 0 | For |
| John Hancock | 2,247,454 | 0 | 0 | 0 | For |
| Invesco | 1,458,667 | 0 | 0 | 0 | For |
| Victory Capital | 1,337,197 | 0 | 0 | 0 | For |
| State Street | 1,254,554 | 16 | 0 | 0 | For |
| Dimensional | 935,911 | 0 | 0 | 0 | For |
| Charles Schwab | 738,419 | 0 | 0 | 0 | For |
| GMO | 568,962 | 0 | 0 | 0 | For |
| American Century | 567,125 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 472,066 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 429,772 | 0 | 0 | 0 | For |
| TIAA | 377,914 | 0 | 0 | 0 | For |
| DAVIS NEW YORK VENTURE FUND INC | 364,350 | 0 | 0 | 0 | For |
| Principal | 330,378 | 0 | 0 | 0 | For |
| First Trust | 315,132 | 0 | 0 | 0 | For |
| DAVIS SERIES INC | 276,843 | 0 | 0 | 0 | For |
| Jackson National | 254,082 | 0 | 0 | 0 | For |
| Goldman Sachs | 207,232 | 0 | 0 | 0 | For |
| FMI FUNDS INC | 190,000 | 0 | 0 | 0 | For |
| Lincoln Financial | 185,672 | 0 | 0 | 0 | For |
| GMO ETF Trust | 176,930 | 0 | 0 | 0 | For |
Showing the 25 largest of 175 asset managers. All 175 are in the interactive database (link above).
Combines 8 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Prior year: 91.9% for (May 15, 2025 meeting) ▲ 2.6 pts
Description as filed by funds: Election of Directors: James E. Davis
Quest Diagnostics Incorporated’s own tally for this item (“Elect Director: James E. Davis”): 88,799,800 for, 5,237,756 against, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “(b) The following nominees for the office of director were elected for terms expiring at the 2027 Annual Meeting of Stockholders, by the following votes:”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 175 asset managers below reported 42,363,762 for, 158,476 against, 21,456 abstained, 93 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,286,597 | 86 | 1 | 0 | For |
| BlackRock | 3,527,385 | 0 | 0 | 0 | For |
| Fidelity | 3,397,386 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,298,943 | 0 | 0 | 0 | For |
| JPMorgan | 2,658,066 | 0 | 0 | 0 | For |
| John Hancock | 2,162,381 | 85,073 | 0 | 0 | For |
| Invesco | 1,458,667 | 0 | 0 | 0 | For |
| Victory Capital | 1,337,197 | 0 | 0 | 0 | For |
| State Street | 1,254,560 | 10 | 0 | 0 | For |
| Dimensional | 931,122 | 4,789 | 0 | 0 | For |
| Charles Schwab | 738,419 | 0 | 0 | 0 | For |
| GMO | 568,962 | 0 | 0 | 0 | For |
| American Century | 567,125 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 472,066 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 429,772 | 0 | 0 | 0 | For |
| TIAA | 377,914 | 0 | 0 | 0 | For |
| DAVIS NEW YORK VENTURE FUND INC | 364,350 | 0 | 0 | 0 | For |
| Principal | 330,378 | 0 | 0 | 0 | For |
| First Trust | 315,132 | 0 | 0 | 0 | For |
| DAVIS SERIES INC | 276,843 | 0 | 0 | 0 | For |
| Jackson National | 254,082 | 0 | 0 | 0 | For |
| Goldman Sachs | 207,232 | 0 | 0 | 0 | For |
| FMI FUNDS INC | 190,000 | 0 | 0 | 0 | For |
| Lincoln Financial | 185,672 | 0 | 0 | 0 | For |
| GMO ETF Trust | 176,930 | 0 | 0 | 0 | For |
Showing the 25 largest of 175 asset managers. All 175 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Prior year: 96.7% for (May 15, 2025 meeting) ▼ 2.7 pts
Description as filed by funds: Election of Directors: Timothy L. Main
Quest Diagnostics Incorporated’s own tally for this item (“Elect Director: Timothy L. Main”): 88,302,767 for, 5,614,920 against, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “(b) The following nominees for the office of director were elected for terms expiring at the 2027 Annual Meeting of Stockholders, by the following votes:”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 175 asset managers below reported 42,380,708 for, 72,656 against, 90,332 abstained, 93 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,286,579 | 103 | 5 | 0 | For |
| BlackRock | 3,527,385 | 0 | 0 | 0 | For |
| Fidelity | 3,397,386 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,298,943 | 0 | 0 | 0 | For |
| JPMorgan | 2,658,066 | 0 | 0 | 0 | For |
| John Hancock | 2,247,454 | 0 | 0 | 0 | For |
| Invesco | 1,458,667 | 0 | 0 | 0 | For |
| Victory Capital | 1,337,197 | 0 | 0 | 0 | For |
| State Street | 1,254,554 | 16 | 0 | 0 | For |
| Dimensional | 935,911 | 0 | 0 | 0 | For |
| Charles Schwab | 738,419 | 0 | 0 | 0 | For |
| GMO | 568,962 | 0 | 0 | 0 | For |
| American Century | 567,125 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 472,066 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 429,772 | 0 | 0 | 0 | For |
| TIAA | 377,914 | 0 | 0 | 0 | For |
| DAVIS NEW YORK VENTURE FUND INC | 364,350 | 0 | 0 | 0 | For |
| Principal | 330,378 | 0 | 0 | 0 | For |
| First Trust | 315,132 | 0 | 0 | 0 | For |
| DAVIS SERIES INC | 276,843 | 0 | 0 | 0 | For |
| Jackson National | 254,082 | 0 | 0 | 0 | For |
| Goldman Sachs | 207,232 | 0 | 0 | 0 | For |
| FMI FUNDS INC | 190,000 | 0 | 0 | 0 | For |
| Lincoln Financial | 185,672 | 0 | 0 | 0 | For |
| GMO ETF Trust | 176,930 | 0 | 0 | 0 | For |
Showing the 25 largest of 175 asset managers. All 175 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
87% Majority: yes · of votes cast
Prior year: 92.2% for (May 15, 2025 meeting) ▼ 5.0 pts
Description as filed by funds: Election of Directors: Timothy M. Ring
Quest Diagnostics Incorporated’s own tally for this item (“Elect Director: Timothy M. Ring”): 81,917,543 for, 11,994,424 against, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “(b) The following nominees for the office of director were elected for terms expiring at the 2027 Annual Meeting of Stockholders, by the following votes:”
Support: 87% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 175 asset managers below reported 42,011,883 for, 510,355 against, 21,460 abstained, 93 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,269,221 | 17,462 | 5 | 0 | For |
| BlackRock | 3,526,711 | 674 | 0 | 0 | For |
| Fidelity | 3,397,386 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,298,943 | 0 | 0 | 0 | For |
| JPMorgan | 2,658,066 | 0 | 0 | 0 | For |
| John Hancock | 2,247,454 | 0 | 0 | 0 | For |
| Invesco | 1,458,667 | 0 | 0 | 0 | For |
| Victory Capital | 1,337,197 | 0 | 0 | 0 | For |
| State Street | 1,254,554 | 16 | 0 | 0 | For |
| Dimensional | 935,911 | 0 | 0 | 0 | For |
| Charles Schwab | 738,175 | 244 | 0 | 0 | For |
| GMO | 568,962 | 0 | 0 | 0 | For |
| American Century | 567,125 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 472,066 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 429,772 | 0 | 0 | 0 | For |
| TIAA | 377,914 | 0 | 0 | 0 | For |
| DAVIS NEW YORK VENTURE FUND INC | 364,350 | 0 | 0 | 0 | For |
| Principal | 330,378 | 0 | 0 | 0 | For |
| First Trust | 315,132 | 0 | 0 | 0 | For |
| DAVIS SERIES INC | 276,843 | 0 | 0 | 0 | For |
| Jackson National | 254,082 | 0 | 0 | 0 | For |
| Goldman Sachs | 207,232 | 0 | 0 | 0 | For |
| FMI FUNDS INC | 190,000 | 0 | 0 | 0 | For |
| Lincoln Financial | 185,672 | 0 | 0 | 0 | For |
| GMO ETF Trust | 176,930 | 0 | 0 | 0 | For |
Showing the 25 largest of 175 asset managers. All 175 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
99.6% Majority: yes · of votes cast
Prior year: 99.5% for (May 15, 2025 meeting) unchanged
Description as filed by funds: Election of Directors: Tracey C. Doi
Quest Diagnostics Incorporated’s own tally for this item (“Elect Director: Tracey C. Doi”): 93,649,938 for, 393,268 against, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “(b) The following nominees for the office of director were elected for terms expiring at the 2027 Annual Meeting of Stockholders, by the following votes:”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 175 asset managers below reported 42,519,353 for, 2,886 against, 21,456 abstained, 93 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,286,679 | 5 | 1 | 0 | For |
| BlackRock | 3,527,385 | 0 | 0 | 0 | For |
| Fidelity | 3,397,386 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,298,943 | 0 | 0 | 0 | For |
| JPMorgan | 2,658,066 | 0 | 0 | 0 | For |
| John Hancock | 2,247,454 | 0 | 0 | 0 | For |
| Invesco | 1,458,667 | 0 | 0 | 0 | For |
| Victory Capital | 1,337,197 | 0 | 0 | 0 | For |
| State Street | 1,254,570 | 0 | 0 | 0 | For |
| Dimensional | 935,911 | 0 | 0 | 0 | For |
| Charles Schwab | 738,419 | 0 | 0 | 0 | For |
| GMO | 568,962 | 0 | 0 | 0 | For |
| American Century | 567,125 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 472,066 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 429,772 | 0 | 0 | 0 | For |
| TIAA | 377,914 | 0 | 0 | 0 | For |
| DAVIS NEW YORK VENTURE FUND INC | 364,350 | 0 | 0 | 0 | For |
| Principal | 330,378 | 0 | 0 | 0 | For |
| First Trust | 315,132 | 0 | 0 | 0 | For |
| DAVIS SERIES INC | 276,843 | 0 | 0 | 0 | For |
| Jackson National | 254,082 | 0 | 0 | 0 | For |
| Goldman Sachs | 207,232 | 0 | 0 | 0 | For |
| FMI FUNDS INC | 190,000 | 0 | 0 | 0 | For |
| Lincoln Financial | 185,672 | 0 | 0 | 0 | For |
| GMO ETF Trust | 176,930 | 0 | 0 | 0 | For |
Showing the 25 largest of 175 asset managers. All 175 are in the interactive database (link above).
Combines 9 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
Prior year: 99.5% for (May 15, 2025 meeting) ▲ 0.2 pts
Description as filed by funds: Election of Directors: Wright L. Lassiter, III
Quest Diagnostics Incorporated’s own tally for this item (“Elect Director: Wright L. Lassiter, III”): 93,802,306 for, 223,154 against, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “(b) The following nominees for the office of director were elected for terms expiring at the 2027 Annual Meeting of Stockholders, by the following votes:”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 175 asset managers below reported 42,519,355 for, 2,885 against, 21,457 abstained, 93 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,286,681 | 4 | 2 | 0 | For |
| BlackRock | 3,527,385 | 0 | 0 | 0 | For |
| Fidelity | 3,397,386 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,298,943 | 0 | 0 | 0 | For |
| JPMorgan | 2,658,066 | 0 | 0 | 0 | For |
| John Hancock | 2,247,454 | 0 | 0 | 0 | For |
| Invesco | 1,458,667 | 0 | 0 | 0 | For |
| Victory Capital | 1,337,197 | 0 | 0 | 0 | For |
| State Street | 1,254,570 | 0 | 0 | 0 | For |
| Dimensional | 935,911 | 0 | 0 | 0 | For |
| Charles Schwab | 738,419 | 0 | 0 | 0 | For |
| GMO | 568,962 | 0 | 0 | 0 | For |
| American Century | 567,125 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 472,066 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 429,772 | 0 | 0 | 0 | For |
| TIAA | 377,914 | 0 | 0 | 0 | For |
| DAVIS NEW YORK VENTURE FUND INC | 364,350 | 0 | 0 | 0 | For |
| Principal | 330,378 | 0 | 0 | 0 | For |
| First Trust | 315,132 | 0 | 0 | 0 | For |
| DAVIS SERIES INC | 276,843 | 0 | 0 | 0 | For |
| Jackson National | 254,082 | 0 | 0 | 0 | For |
| Goldman Sachs | 207,232 | 0 | 0 | 0 | For |
| FMI FUNDS INC | 190,000 | 0 | 0 | 0 | For |
| Lincoln Financial | 185,672 | 0 | 0 | 0 | For |
| GMO ETF Trust | 176,930 | 0 | 0 | 0 | For |
Showing the 25 largest of 175 asset managers. All 175 are in the interactive database (link above).
Combines 8 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Prior year: 99.6% for (May 15, 2025 meeting) ▲ 0.2 pts
Description as filed by funds: Election of Directors: Luis A. Diaz, Jr., M.D.
Quest Diagnostics Incorporated’s own tally for this item (“Elect Director: Luis A. Diaz, Jr., M.D.”): 93,909,369 for, 110,114 against, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “(b) The following nominees for the office of director were elected for terms expiring at the 2027 Annual Meeting of Stockholders, by the following votes:”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 174 asset managers below reported 42,519,356 for, 2,882 against, 21,457 abstained, 93 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,286,682 | 1 | 2 | 0 | For |
| BlackRock | 3,527,385 | 0 | 0 | 0 | For |
| Fidelity | 3,397,386 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,298,943 | 0 | 0 | 0 | For |
| JPMorgan | 2,658,066 | 0 | 0 | 0 | For |
| John Hancock | 2,247,454 | 0 | 0 | 0 | For |
| Invesco | 1,458,667 | 0 | 0 | 0 | For |
| Victory Capital | 1,337,197 | 0 | 0 | 0 | For |
| State Street | 1,254,570 | 0 | 0 | 0 | For |
| Dimensional | 935,911 | 0 | 0 | 0 | For |
| Charles Schwab | 738,419 | 0 | 0 | 0 | For |
| GMO | 568,962 | 0 | 0 | 0 | For |
| American Century | 567,125 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 472,066 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 429,772 | 0 | 0 | 0 | For |
| TIAA | 377,914 | 0 | 0 | 0 | For |
| DAVIS NEW YORK VENTURE FUND INC | 364,350 | 0 | 0 | 0 | For |
| Principal | 330,378 | 0 | 0 | 0 | For |
| First Trust | 315,132 | 0 | 0 | 0 | For |
| DAVIS SERIES INC | 276,843 | 0 | 0 | 0 | For |
| Jackson National | 254,082 | 0 | 0 | 0 | For |
| Goldman Sachs | 207,232 | 0 | 0 | 0 | For |
| FMI FUNDS INC | 190,000 | 0 | 0 | 0 | For |
| Lincoln Financial | 185,672 | 0 | 0 | 0 | For |
| GMO ETF Trust | 176,930 | 0 | 0 | 0 | For |
Showing the 25 largest of 174 asset managers. All 174 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
Prior year: 99.7% for (May 15, 2025 meeting) ▲ 0.1 pts
Description as filed by funds: Election of Directors: Robert B. Carter
Quest Diagnostics Incorporated’s own tally for this item (“Elect Director: Robert B. Carter”): 93,821,069 for, 205,166 against, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “(b) The following nominees for the office of director were elected for terms expiring at the 2027 Annual Meeting of Stockholders, by the following votes:”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 174 asset managers below reported 42,519,355 for, 2,884 against, 21,457 abstained, 93 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,286,681 | 3 | 2 | 0 | For |
| BlackRock | 3,527,385 | 0 | 0 | 0 | For |
| Fidelity | 3,397,386 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,298,943 | 0 | 0 | 0 | For |
| JPMorgan | 2,658,066 | 0 | 0 | 0 | For |
| John Hancock | 2,247,454 | 0 | 0 | 0 | For |
| Invesco | 1,458,667 | 0 | 0 | 0 | For |
| Victory Capital | 1,337,197 | 0 | 0 | 0 | For |
| State Street | 1,254,570 | 0 | 0 | 0 | For |
| Dimensional | 935,911 | 0 | 0 | 0 | For |
| Charles Schwab | 738,419 | 0 | 0 | 0 | For |
| GMO | 568,962 | 0 | 0 | 0 | For |
| American Century | 567,125 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 472,066 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 429,772 | 0 | 0 | 0 | For |
| TIAA | 377,914 | 0 | 0 | 0 | For |
| DAVIS NEW YORK VENTURE FUND INC | 364,350 | 0 | 0 | 0 | For |
| Principal | 330,378 | 0 | 0 | 0 | For |
| First Trust | 315,132 | 0 | 0 | 0 | For |
| DAVIS SERIES INC | 276,843 | 0 | 0 | 0 | For |
| Jackson National | 254,082 | 0 | 0 | 0 | For |
| Goldman Sachs | 207,232 | 0 | 0 | 0 | For |
| FMI FUNDS INC | 190,000 | 0 | 0 | 0 | For |
| Lincoln Financial | 185,672 | 0 | 0 | 0 | For |
| GMO ETF Trust | 176,930 | 0 | 0 | 0 | For |
Showing the 25 largest of 174 asset managers. All 174 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
99.4% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Timothy C. Wentworth
Quest Diagnostics Incorporated’s own tally for this item (“Elect Director: Timothy C. Wentworth”): 93,427,490 for, 597,095 against, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “(b) The following nominees for the office of director were elected for terms expiring at the 2027 Annual Meeting of Stockholders, by the following votes:”
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 174 asset managers below reported 42,519,348 for, 2,892 against, 21,457 abstained, 93 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,286,674 | 11 | 2 | 0 | For |
| BlackRock | 3,527,385 | 0 | 0 | 0 | For |
| Fidelity | 3,397,386 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,298,943 | 0 | 0 | 0 | For |
| JPMorgan | 2,658,066 | 0 | 0 | 0 | For |
| John Hancock | 2,247,454 | 0 | 0 | 0 | For |
| Invesco | 1,458,667 | 0 | 0 | 0 | For |
| Victory Capital | 1,337,197 | 0 | 0 | 0 | For |
| State Street | 1,254,570 | 0 | 0 | 0 | For |
| Dimensional | 935,911 | 0 | 0 | 0 | For |
| Charles Schwab | 738,419 | 0 | 0 | 0 | For |
| GMO | 568,962 | 0 | 0 | 0 | For |
| American Century | 567,125 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 472,066 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 429,772 | 0 | 0 | 0 | For |
| TIAA | 377,914 | 0 | 0 | 0 | For |
| DAVIS NEW YORK VENTURE FUND INC | 364,350 | 0 | 0 | 0 | For |
| Principal | 330,378 | 0 | 0 | 0 | For |
| First Trust | 315,132 | 0 | 0 | 0 | For |
| DAVIS SERIES INC | 276,843 | 0 | 0 | 0 | For |
| Jackson National | 254,082 | 0 | 0 | 0 | For |
| Goldman Sachs | 207,232 | 0 | 0 | 0 | For |
| FMI FUNDS INC | 190,000 | 0 | 0 | 0 | For |
| Lincoln Financial | 185,672 | 0 | 0 | 0 | For |
| GMO ETF Trust | 176,930 | 0 | 0 | 0 | For |
Showing the 25 largest of 174 asset managers. All 174 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
89% Majority: yes · of votes cast
Prior year: 92.6% for (May 15, 2025 meeting) ▼ 3.5 pts
Description as filed by funds: Election of Directors: Vicky B. Gregg
Quest Diagnostics Incorporated’s own tally for this item (“Elect Director: Vicky B. Gregg”): 83,814,387 for, 10,232,574 against, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “(b) The following nominees for the office of director were elected for terms expiring at the 2027 Annual Meeting of Stockholders, by the following votes:”
Support: 89% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 174 asset managers below reported 38,947,509 for, 3,574,729 against, 21,456 abstained, 93 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,286,496 | 188 | 1 | 0 | For |
| BlackRock | 3,527,385 | 0 | 0 | 0 | For |
| Fidelity | 3,354,695 | 42,691 | 0 | 0 | For |
| T. Rowe Price | 0 | 3,298,943 | 0 | 0 | Against |
| JPMorgan | 2,658,066 | 0 | 0 | 0 | For |
| John Hancock | 2,247,454 | 0 | 0 | 0 | For |
| Invesco | 1,458,667 | 0 | 0 | 0 | For |
| Victory Capital | 1,337,197 | 0 | 0 | 0 | For |
| State Street | 1,254,554 | 16 | 0 | 0 | For |
| Dimensional | 935,911 | 0 | 0 | 0 | For |
| Charles Schwab | 738,419 | 0 | 0 | 0 | For |
| GMO | 568,962 | 0 | 0 | 0 | For |
| American Century | 567,125 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 472,066 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 429,772 | 0 | 0 | 0 | For |
| TIAA | 377,914 | 0 | 0 | 0 | For |
| DAVIS NEW YORK VENTURE FUND INC | 364,350 | 0 | 0 | 0 | For |
| Principal | 330,378 | 0 | 0 | 0 | For |
| First Trust | 315,132 | 0 | 0 | 0 | For |
| DAVIS SERIES INC | 276,843 | 0 | 0 | 0 | For |
| Jackson National | 130,325 | 123,757 | 0 | 0 | Mixed |
| Goldman Sachs | 207,232 | 0 | 0 | 0 | For |
| FMI FUNDS INC | 190,000 | 0 | 0 | 0 | For |
| Lincoln Financial | 174,097 | 11,575 | 0 | 0 | Mixed |
| GMO ETF Trust | 176,930 | 0 | 0 | 0 | For |
Showing the 25 largest of 174 asset managers. All 174 are in the interactive database (link above).
Combines 21 wordings of this item as funds reported it.
92% Approved · of votes cast
Prior year: 90.9% for (May 15, 2025 meeting) ▲ 1.5 pts
Description as filed by funds: An advisory resolution to approve the executive officer compensation disclosed in the Company's 2026 proxy statement.
Quest Diagnostics Incorporated’s own tally for this item (“The advisory resolution to approve the executive officer compensation disclosed in the Company's 2026 Proxy Statement was approved by the following votes:”): 86,869,738 for, 7,152,448 against — passed, per its Form 8-K filed May 21, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The advisory resolution to approve the executive officer compensation disclosed in the Company's 2026 Proxy Statement was approved by the following votes:”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of Quest Diagnostics Incorporated’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Advisory Vote to Ratify Named Executive Officers' Compensation” (32 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,286,567 | 117 | 2 | 0 | For |
| BlackRock | 3,526,242 | 1,143 | 0 | 0 | For |
| Fidelity | 3,397,386 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,266,443 | 32,500 | 0 | 0 | For |
| JPMorgan | 2,658,066 | 0 | 0 | 0 | For |
| John Hancock | 2,247,454 | 0 | 0 | 0 | For |
| Invesco | 1,458,667 | 0 | 0 | 0 | For |
| Victory Capital | 1,337,197 | 0 | 0 | 0 | For |
| State Street | 1,254,415 | 155 | 0 | 0 | For |
| Dimensional | 935,911 | 0 | 0 | 0 | For |
| Charles Schwab | 738,419 | 0 | 0 | 0 | For |
| GMO | 568,962 | 0 | 0 | 0 | For |
| American Century | 567,125 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 472,066 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 429,772 | 0 | 0 | 0 | For |
| TIAA | 377,914 | 0 | 0 | 0 | For |
| DAVIS NEW YORK VENTURE FUND INC | 364,350 | 0 | 0 | 0 | For |
| Principal | 330,378 | 0 | 0 | 0 | For |
| First Trust | 315,132 | 0 | 0 | 0 | For |
| DAVIS SERIES INC | 276,843 | 0 | 0 | 0 | For |
| Jackson National | 254,082 | 0 | 0 | 0 | For |
| Goldman Sachs | 207,232 | 0 | 0 | 0 | For |
| FMI FUNDS INC | 0 | 190,000 | 0 | 0 | Against |
| GMO ETF Trust | 176,930 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 175,078 | 0 | 0 | 0 | For |
Fund voting reports, all 170 managers: 42,001,904 for, 384,266 against, 21,457 abstained, 93 not voted, 77 mixed. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 6,516,898 | 47,609 | 0 | 0 | For |
| BlackRock | 3,825,364 | 50,166 | 0 | 0 | For |
| Boston Partners | 3,483,429 | 0 | 0 | 0 | For |
| State Street | 3,371,387 | 52,379 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 3,076,826 | 0 | 0 | 0 | For |
| EdgePoint Investment Group Inc. | 2,241,487 | 0 | 0 | 0 | For |
| Victory Capital | 1,756,908 | 0 | 0 | 0 | For |
| Grantham, Mayo, Van Otterloo & Co. LLC | 1,644,108 | 0 | 0 | 0 | For |
| Invesco | 1,620,085 | 0 | 0 | 0 | For |
| DAVIS SELECTED ADVISERS | 1,516,804 | 0 | 0 | 0 | For |
| WELLS FARGO CLEARING SERVICES, LLC | 1,441,295 | 0 | 0 | 0 | For |
| Vanguard | 1,155,523 | 0 | 0 | 0 | For |
| Northern Trust | 905,736 | 7,189 | 0 | 0 | For |
| Fidelity | 876,034 | 0 | 0 | 0 | For |
| American Century | 830,555 | 0 | 0 | 0 | For |
| Charles Schwab | 758,766 | 0 | 0 | 0 | For |
| Goldman Sachs | 686,602 | 27 | 0 | 0 | For |
| PGGM Investments | 0 | 675,013 | 0 | 0 | Against |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 598,472 | 0 | 0 | 0 | For |
| AllianceBernstein | 592,393 | 0 | 0 | 0 | For |
| PRINCIPAL GLOBAL INVESTORS | 524,311 | 0 | 0 | 0 | For |
| UBS | 461,999 | 0 | 0 | 0 | For |
| CRAWFORD INVESTMENT COUNSEL INC | 449,834 | 0 | 0 | 0 | For |
| Nuveen | 428,267 | 0 | 0 | 0 | For |
| Dimensional | 425,276 | 0 | 0 | 0 | For |
Institutional-manager reports, all 764 managers: 51,242,352 for, 3,943,465 against, 4,303 abstained, 48,620 not voted. Showing the 25 largest; every one is in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
94% Approved · of votes cast
Prior year: 93.3% for (May 15, 2025 meeting) ▲ 1.1 pts
Description as filed by funds: Ratification of the appointment of our independent registered public accounting firm for 2026.
Quest Diagnostics Incorporated’s own tally for this item (“The ratification of the appointment of PricewaterhouseCoopers as the Company's independent registered public accounting firm for 2026 was approved by the following votes:”): 97,340,034 for, 5,809,995 against — passed, per its Form 8-K filed May 21, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The ratification of the appointment of PricewaterhouseCoopers as the Company's independent registered public accounting firm for 2026 was approved by the following votes:”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of Quest Diagnostics Incorporated’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Ratify PricewaterhouseCoopers LLP as Auditors” (5 managers, 121,814 for).
The 173 asset managers below reported 42,213,377 for, 187,149 against, 21,456 abstained, 93 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,269,323 | 17,362 | 1 | 0 | For |
| BlackRock | 3,527,009 | 376 | 0 | 0 | For |
| Fidelity | 3,397,386 | 0 | 0 | 0 | For |
| T. Rowe Price | 3,298,943 | 0 | 0 | 0 | For |
| JPMorgan | 2,658,066 | 0 | 0 | 0 | For |
| John Hancock | 2,247,454 | 0 | 0 | 0 | For |
| Invesco | 1,458,667 | 0 | 0 | 0 | For |
| Victory Capital | 1,337,197 | 0 | 0 | 0 | For |
| State Street | 1,254,554 | 16 | 0 | 0 | For |
| Dimensional | 935,911 | 0 | 0 | 0 | For |
| Charles Schwab | 738,419 | 0 | 0 | 0 | For |
| GMO | 568,962 | 0 | 0 | 0 | For |
| American Century | 567,125 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 472,066 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 429,772 | 0 | 0 | 0 | For |
| TIAA | 377,914 | 0 | 0 | 0 | For |
| DAVIS NEW YORK VENTURE FUND INC | 364,350 | 0 | 0 | 0 | For |
| Principal | 330,378 | 0 | 0 | 0 | For |
| First Trust | 315,132 | 0 | 0 | 0 | For |
| DAVIS SERIES INC | 276,843 | 0 | 0 | 0 | For |
| Jackson National | 254,082 | 0 | 0 | 0 | For |
| Goldman Sachs | 207,232 | 0 | 0 | 0 | For |
| FMI FUNDS INC | 190,000 | 0 | 0 | 0 | For |
| GMO ETF Trust | 176,930 | 0 | 0 | 0 | For |
| CARILLON SERIES TRUST | 175,078 | 0 | 0 | 0 | For |
Showing the 25 largest of 173 asset managers. All 173 are in the interactive database (link above).
Proposed by: John Chevedden
Combines 6 wordings of this item as funds reported it.
26% Not approved · of votes cast
Description as filed by funds: Stockholder proposal regarding an independent board chairman, if properly presented at the Annual Meeting.
Quest Diagnostics Incorporated’s own tally for this item (“The stockholder proposal regarding an independent board chairman was not approved by the following votes:”): 23,999,636 for, 69,792,819 against — failed, per its Form 8-K filed May 21, 2026 (Item 5.07).
Reported outcome: Not approved, in the filing’s own words: “The stockholder proposal regarding an independent board chairman was not approved by the following votes:”
Support: 26% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 173 asset managers below reported 5,364,778 for, 37,037,783 against, 21,460 abstained, 93 not voted, 100 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 17,686 | 13,268,995 | 5 | 0 | Against |
| BlackRock | 1,817 | 3,525,568 | 0 | 0 | Against |
| Fidelity | 42,300 | 3,355,086 | 0 | 0 | Against |
| T. Rowe Price | 32,500 | 3,266,443 | 0 | 0 | Against |
| JPMorgan | 0 | 2,658,066 | 0 | 0 | Against |
| John Hancock | 2,123,202 | 124,252 | 0 | 0 | Mixed |
| Invesco | 1,417,526 | 41,141 | 0 | 0 | For |
| Victory Capital | 0 | 1,337,197 | 0 | 0 | Against |
| State Street | 335 | 1,254,235 | 0 | 0 | Against |
| Dimensional | 0 | 935,911 | 0 | 0 | Against |
| Charles Schwab | 244 | 738,175 | 0 | 0 | Against |
| GMO | 0 | 568,962 | 0 | 0 | Against |
| American Century | 0 | 567,125 | 0 | 0 | Against |
| Columbia Threadneedle | 472,066 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 0 | 429,772 | 0 | 0 | Against |
| TIAA | 0 | 377,914 | 0 | 0 | Against |
| DAVIS NEW YORK VENTURE FUND INC | 0 | 364,350 | 0 | 0 | Against |
| Principal | 0 | 330,378 | 0 | 0 | Against |
| First Trust | 0 | 315,132 | 0 | 0 | Against |
| DAVIS SERIES INC | 0 | 276,843 | 0 | 0 | Against |
| Jackson National | 0 | 254,082 | 0 | 0 | Against |
| Goldman Sachs | 0 | 207,232 | 0 | 0 | Against |
| FMI FUNDS INC | 190,000 | 0 | 0 | 0 | For |
| GMO ETF Trust | 0 | 176,930 | 0 | 0 | Against |
| CARILLON SERIES TRUST | 0 | 175,078 | 0 | 0 | Against |
Showing the 25 largest of 173 asset managers. All 173 are in the interactive database (link above).
Not shown here: this season’s fund filings also report 1 item from the meeting of May 15, 2025, which belongs to the 2024-2025 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 110,696,429 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 12.00% |
| 2 | BlackRock | 3.19% |
| 3 | Fidelity | 3.07% |
| 4 | T. Rowe Price | 2.98% |
| 5 | JPMorgan | 2.40% |
| 6 | John Hancock | 2.03% |
| 7 | Invesco | 1.32% |
| 8 | Victory Capital | 1.21% |
| 9 | State Street | 1.13% |
| 10 | Dimensional | 0.85% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | T. Rowe Price | 5.93% |
| 2 | BlackRock | 3.50% |
| 3 | Boston Partners | 3.15% |
| 4 | State Street | 3.09% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 2.78% |
| 6 | EdgePoint Investment Group Inc. | 2.02% |
| 7 | Victory Capital | 1.59% |
| 8 | Grantham, Mayo, Van Otterloo & Co. LLC | 1.49% |
| 9 | Invesco | 1.46% |
| 10 | DAVIS SELECTED ADVISERS | 1.37% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Vanguard Group | 14,392,082 | 13.00% | Form 13F, quarter ended March 31, 2026 |
| BlackRock, Inc. | 9,308,815 | 8.41% | Proxy statement (DEF 14A), proxy filed April 6, 2026 |
| T. Rowe Price Associates, Inc. | 5,428,244 | 4.90% | Schedule 13G, filed August 14, 2026 |
| State Street | 5,380,821 | 4.86% | Form 13F, quarter ended March 31, 2026 |
| JPMorgan Chase | 3,846,456 | 3.47% | Form 13F, quarter ended March 31, 2026 |
| Geode Capital | 3,086,308 | 2.79% | Form 13F, quarter ended March 31, 2026 |
| Morgan Stanley | 2,693,568 | 2.43% | Form 13F, quarter ended March 31, 2026 |
| Dimensional Fund Advisors | 1,949,535 | 1.76% | Form 13F, quarter ended March 31, 2026 |
| Invesco | 1,638,487 | 1.48% | Form 13F, quarter ended March 31, 2026 |
| Goldman Sachs | 1,348,694 | 1.22% | Form 13F, quarter ended March 31, 2026 |
Percentages above are of 110,696,429 shares outstanding, as reported by Quest Diagnostics Incorporated on its Form 10-Q dated April 15, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At Quest Diagnostics Incorporated's shareholder meeting held May 20, 2026, in the 2025-2026 proxy season, 928 asset managers reported votes on at least one of its 14 ballot items in their SEC Form N-PX filings, covering 12,745 separate fund positions. On the most widely held item on that ballot — An advisory resolution to approve the executive officer compensation disclosed in the Company's… — Quest Diagnostics Incorporated's filing reports the proposal as approved, with 92% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Quest Diagnostics Incorporated's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 21, 2026.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Quest Diagnostics Incorporated’s 10-Q dated April 15, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
Quest Diagnostics Incorporated proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Proxy Votes Now, “Quest Diagnostics (DGX) 2026 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/quest-diagnostics-inc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.